Paradigm Shift in Primary Care - Defining New Roles in Occupational Therapy
Autor: onlypriyask • February 29, 2016 • Research Paper • 5,457 Words (22 Pages) • 888 Views
Financial Analysis
[pic 1]
Name: Medtronic, Inc. (NYSE- MDT)
Principal Office: 710 Medtronic Pkwy., N.E. Minneapolis, MN 55432, (763) 514-4000
Website: www.medtronic.com
NAICS: 325412: Pharmaceutical Preparation Manufacturing
Primary SIC: 3845- Electromedical and Electrotherapeutic Apparatus Manufacturing
Secondary SIC: 339112- Surgical and Medical Instrument Manufacturing.
Auditor: PricewaterhouseCoopers LLP, New York, NY
Primary Bank: Wells Fargo Bank, N.A., Minneapolis, MN
Company started: 1949
Number of Employees: 45,499
Table of Contents:
Sl. | Topics | Page |
1 | General Description of Medtronic Inc. | 1 |
2 | Challenges 2.a. Medical Device Industry 2.b. Medtronic Inc. | 3 |
3 | Ethical issues | 5 |
4 | Financial Analysis 4.a. Financial Analysis of 10K 4.b.Cost and expenses analysis 4.c. Financial Ratios | 6 8 9 |
5 | Industry/Competitor Analysis | 11 |
6 | Conclusion | 13 |
7 | Bibliography | 14 |
By Geethapriya Setty
(100918266)
Address: 1300 Hennepin Ave, Apt M101, Minneapolis, Minnesota-55403
Section 1: General Description of Medtronic Inc.
Medtronic Inc., a medical technology company, was founded in 1949 by Earl Bakken and Palmer Hermundslie. It was incorporated in 1957 in Minneapolis, Minnesota. They were the first to create a wearable cardiac pacemaker in 1957. They have been able to expand their business from a small repair company, which serviced medical equipment in hospitals, to being able to serve physicians and patients in more than 120 countries worldwide. From then on they focused on cardiac rhythm technology that makes up approximately 52% of their net sales (fiscal year 2012). [1]Along with CRDM, they also have an additional 7 areas they specialize in which are as follows-
...